Hypertensive disorders in pregnancy can lead to serious complications, prompting the need for medication such as hydralazine and labetalol to lower blood pressure.
A systematic review of 19 randomized controlled trials compared the effectiveness and safety of intravenous labetalol versus hydralazine in managing these conditions.
The findings indicated no significant differences in blood pressure outcomes between the two medications, but labetalol was found to significantly reduce instances of maternal hypotension compared to hydralazine.